Monsanto/Bayer AG’s glyphosate-based Roundup weed killer was found to be a “substantial factor” in causing non-Hodgkin’s lymphoma in a California man, as the trial proceeds to its next phase to determine liability and damages.
In a landmark verdict that could affect numerous other cases, a federal jury in San Francisco found Roundup herbicide to be a significant contributing factor in causing the cancer of a man from Santa Rosa, California. During the trial, 70-year-old Edwin Hardeman alleged that his decades-long exposure to the Monsanto product had led him to develop a cancer that affects the immune system, called non-Hodgkin’s lymphoma (NHL).
The trial will now proceed to the next phase where the jury is set to determine the liability and damages in the case.
Tuesday’s ruling follows another pivotal verdict against Monsanto in August, where the jury awarded terminal cancer patient Dewayne Johnson a staggering $289 million in damages after ruling that the biotechnology corporation failed to properly warn users of Roundup’s health hazards.
Across the US alone, the German pharmaceutical company Bayer, which purchased Monsanto last year, is potentially facing thousands of similar lawsuits involving Roundup weed killer.
“Monsanto has placed an unsafe product on the market, has manipulated the science and manipulated public opinion and has consistently misled people into believing Roundup is safe,” Jennifer Moore, one of the plaintiff’s attorneys, said before the verdict, after the defense team claimed at the trial that the company had “bullied” researchers to suppress negative studies about the weed killer.